Core Viewpoint - The company reported a revenue growth of 13.69% and a net profit increase of 17.68% for the first half of 2025, driven by strategic market focus and product innovation [1][2]. Group 1: Performance Analysis - The company's revenue for the first half of 2025 reached 236 million yuan, with a net profit of 23.53 million yuan, and a non-recurring net profit of 21.84 million yuan, reflecting year-on-year growth rates of 13.69%, 17.68%, and 27.46% respectively [1]. - The company is committed to a market strategy of "deepening domestic and breaking into international" and a product strategy of "diversified species and products, full nutritional support" [1]. Group 2: Future Growth Strategy - The company plans to continue its established strategy in the second half of the year, focusing on core customers in the domestic market and implementing the "expansion of one product project" to balance customer costs and value through dual service and cross-selling [2]. - In the international market, the company aims to enhance market development by adopting a "go out and invite in" approach, while also increasing R&D investment to develop efficient, safe, and environmentally friendly products [2]. Group 3: Product and Market Situation - The company emphasizes R&D for product innovation, aiming to enrich its product offerings and develop new solutions to mitigate risks associated with the cyclical nature of the livestock industry [3]. - The overseas business grew by over 20% in the first half of the year, with a sales network established in over 40 countries and regions, and the company plans to continue investing in international market development [3]. Group 4: Raw Material Price Management - The company has established long-term partnerships with upstream suppliers to mitigate the impact of raw material price fluctuations, employing strategic procurement and optimized inventory management [4]. - Continuous optimization of product structure and adherence to the company's mission are key to meeting diverse customer needs and enhancing product competitiveness [4].

Core Viewpoint - The company is addressing challenges related to low gross margins in its e-commerce channel and rising raw material costs, while outlining strategies to improve sales and operational quality. Group 1: E-commerce Channel - The company's e-commerce gross margin is low primarily due to product structure and high platform and logistics costs [1] - Strategies to enhance sales and improve gross margin include optimizing product structure, launching exclusive products, increasing Douyin live streaming, and strengthening content marketing [1] Group 2: Raw Material Costs - In the first half of 2025, the cost of sunflower seed raw materials increased by approximately 10-15% year-on-year [1] - The company plans to optimize sunflower seed procurement methods, accelerate decision-making efficiency, and increase direct procurement scale to mitigate raw material price fluctuations [1] - The company will also enhance its overseas procurement strategy and conduct trials for overseas sunflower seed cultivation [1] Group 3: Product Sales Layout - The company's konjac products are currently in trial sales, with availability in some Southeast Asian countries and online channels, and plans for offline launch in key domestic cities [1]

Core Viewpoint - The company is actively implementing strategies to mitigate the impact of raw material price fluctuations on its operations through various measures [1] Group 1: Company Strategies - The company is developing multiple suppliers to introduce competitive materials [1] - Continuous optimization of supply chain management is being pursued [1] - Internal initiatives for cost reduction and quality improvement are being implemented [1] - The company is constructing a rooftop photovoltaic power generation project to reduce electricity costs [1] - Negotiations with customers for re-pricing and optimizing order structures are ongoing to minimize risks from material price volatility [1]

证券代码：603079 证券简称：圣达生物 公告编号：2025-018 浙江圣达生物药业股份有限公司 2025年第一季度主要经营数据公告 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第3号行业信息披露：第十三 号——化工》（2022年修订）及《上市公司自律监管指引第3号行业信息披露： 第十四号——食品制造》（2022年修订）的要求，现将浙江圣达生物药业股份 有限公司（以下简称"公司"）2025年第一季度主要经营数据披露如下： 单位：万元 主要产品 营业收入 （境内） 较上年同期 增减（%） 营业收入 （境外） 较上年同期 增减（%） 维生素 2,385.63 -0.77 3,191.65 -10.83 生物保鲜剂及功 能配料 10,040.09 30.11 2,593.42 22.93 比上涨26.19%；生物保鲜剂及功能配料平均销售价格较上年同期下降17.33%， 环比下降2.95%。 2、主要原材料价格（不含税）变动情况 第一季度，公司主要原材料三氨基盐平均采购价格较上年同期上涨 ...